Krystal Biotech, Inc.KRYSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeStrong
Percentile Rank78
3Y CAGR+75.4%
5Y CAGR+102.3%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+75.4%/yr
vs +50.2%/yr prior
5Y CAGR
+102.3%/yr
Recent deceleration
Acceleration
+25.2pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
33.9x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $28.18M | -5.0% |
| 2024 | $29.66M | -75.8% |
| 2023 | $122.62M | +2248.7% |
| 2022 | $5.22M | +503.2% |
| 2021 | $-1.29M | -255.6% |
| 2020 | $832000.00 | -72.2% |
| 2019 | $2.99M | +191.4% |
| 2018 | $1.03M | +132.6% |
| 2017 | $-3.15M | -44871.4% |
| 2016 | $-7000.00 | - |